The complexity and duration of this treatment leads to poor disease control

A model of oxidative stress was used to record the time taken to depolarisation and hypercontracture of cardiac myocytes upon drug treatment and western blot analysis was used to evaluate the levels signalling proteins. Data on the effects of mdivi-1 on the cytotoxicity of doxorubicin was also assessed in HL60 cell line. Oxidative stress in CY5-SE response to the positively charged fluorescent dye, tetramethylrhodamine methyl ester and laser illumination was used to record the time taken to depolarisation and hypercontraction of cardiac myocytes. Briefly, TMRM was used as it penetrates and concentrates in negatively charged mitochondria due to its charged nature. Laser illumination causes the TMRM to release ROS from the mitochondria, leading to depolarisation of the mitochondrial membrane. The release of TMRM along with the content of the mitochondria into the cytoplasm can be observed as an increase in fluorescence intensity on the confocal microscope. Oxidative stress was continued until the cells underwent hypercontracture, marking the point of ATP depletion and cell death. The time taken to depolarisation and hypercontracture were recorded. Following the overnight incubation of the isolated cardiac myocytes, the cells were transferred to laminin-coated cover slips and allowed to adhere for 3 hours prior to being prepared for drug treatment and microscopy. The adherent cardiac myocytes were then incubated for 15 minutes in microscopy buffer containing 3��M TMRM. The TMRM was then washed away and the cells were incubated without or with the drugs for 10 minutes before being placed on the confocal microscope. Cells were assigned to the following groups: Control group, incubated with microscopy buffer alone for 10 minutes; incubation with 1��M doxorubicin and in presence of mdivi-1 or incubation with mdivi-1 alone. The data were expressed as mean �� SEM. Infarct size, the times taken to depolarisation and hypercontracture and the western blot data were tested for group differences using one way analysis of variance with Fishers post hoc tests. The 1187431-43-1 colorimetric MTT assay demonstrated as expected that doxorubicin reduced the viability of HL60 cells by 33% as compared to the non-treated controls. Coadministration of doxorubicin with mdivi-1 did no